Diabetes Mellitus as a Model of Psychosomatic and Somatopsychic Interrelationships by Wasserman, Ludvig I. & Trifonova, Elena A.
The article reviews research on the problem of interrelationship between different physical and psychosocial factors in type 1 diabetes
mellitus (DM1). The authors consider methodological principles of health-related quality of life (HRQoL) assessment in DM1 patients
and stress the need for an integrated biopsychosocial approach to the management of the disease. DM1 is a chronic metabolic disease
with an absolute requirement for insulin replacement therapy. The stress-inducing nature of DM1 is associated with its unexpected and
dramatic manifestation in juvenile years, life-threatening nature of severe hypo-/hyperglycaemias and long-term complications, with
the burden of diabetes self-management, threat of work disability, employment and career problems etc. These features of DM1 increase
the likelihood of the development of anxiety and depressive disorders, which, in turn, may negatively influence the course of diabetes
and in particular, diabetes self-care. This necessitates early diagnosis of emotional and behavioral disturbances in DM1 using self-report
instruments as well as clinical assessment. Evidence suggests that active problem-focused coping behavior and adequate social support
promote adherence to diabetes regimes and may act as a buffer against negative effects of the disease on HRQoL in DM1 patients.
The core element in the HRQoL structure is personal disease picture (as opposed by objective clinical picture) – the cognitive-affective-
behavioral complex reflecting the patient’s personal perception of the disease. Examination of the personal disease picture and attitude
towards the ailment in DM1 patients may help to improve understanding of the mechanisms of poor adjustment. Problems in disease
adjustment can be detected also by diabetes-specific HRQoL assessment. The measures of HRQoL can be applied as screening instruments
useful in increasing the effectiveness of patient-provider interactions and diabetes care.
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El artículo revisa la investigación del problema de la interrelación entre diferentes factores físicos y psicosociales en la diabetes
melitus tipo 1 (DM1). Los autores consideran los principios de la evaluación de la calidad de vida relacionada con la salud
(CVRS) en pacientes de DM1 y ponen de manifiesto la necesidad de un abordaje biopsicosocial integrado del manejo de la
enfermedad. La DM1 es una enfermedad metabólica crónica con una necesidad absoluta de terapia de reemplazo de insulina.
La naturaleza estresante de la DM1 se asocia con su aparición inesperada y dramática durante los años de juventud, la naturaleza
peligrosa de las hipo e hiperglucemias y las complicaciones a largo plazo, con la carga del auto-cuidado de la diabetes, la
amenaza de discapacidad laboral, problemas de empleo y carrera, etc. Estas características de la DM1 aumentan la probabilidad
de desarrollar trastornos de ansiedad y depresivos que, a su vez, pueden afectar negativamente el curso de la diabetes y, en
particular, el auto-cuidado de la diabetes. Esto requiere un diagnóstico temprano de los trastornos emocionales y comportamentales
en los enfermos de DM1, empleando instrumentos de auto-informe además de la evaluación clínica. La evidencia sugiere que
el comportamiento de afrontamiento activo centrado en los problemas y el apoyo social adecuado promocionan la adherencia
a los regímenes diabéticos y pueden amortiguar los efectos negativos de la enfermedad en la CVRS en los pacientes con DM1.
El elemento esencial en la estructura de la CVRS es el cuadro clínico personal (en contraste con el cuadro clínico objetivo)—
el complejo cognitivo-afectivo-conductual que refleja la percepción personal que tiene el paciente de su enfermedad. El examen
del cuadro de enfermedad personal y la actitud hacia la enfermedad en los pacientes con DM1 puede mejorar la comprensión
de los mecanismos de desadaptación. Los problemas en la adaptación a la enfermedad también pueden detectarse por medio
de la evaluación de la CVRS específica para la diabetes. Las medidas de CVRS pueden aplicarse como instrumentos de criba
útiles para incrementar la efectividad de las interacciones paciente-cuidador y del cuidado de la diabetes. 
Palabras clave: diabetes melitus, factores psicosociales, adaptación a la enfermedad, calidad de vida relacionada con la salud,
evaluación psicológica
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Diabetes mellitus as a multidimensional
biopsychosocial problem
Diabetes mellitus (DM) is one of the most relevant issues
of contemporary healthcare due to its prevalence (4-5% of the
population in developed countries), its physical and
psychosocial consequences for patients (Barrett, 2004), and
its economic impact on society  (Rubin, Altman, & Mendelson,
1994). DM is the most widespread incurable endocrine disease
associated with absolute or relative insulin deficiency.
A multitude of studies (Delamater et al., 2001; Glasgow,
Ruggiero, Eakin, Dryfoos, & Chobanian, 1997; Glasgow,
Toobert, & Gillette, 2001; Jacobson, de Groot, & Samson,
1997; Polonsky, 2000) have demonstrated that improvement
in health-related quality of life (HRQoL) is unlikely without
considering all dimensions of personal functioning: physical,
social and undoubtedly, psychological. A comprehensive
approach to the person suffering from this disease guarantees
greater success in diabetes management and the patient’s
psychosocial adjustment. However, the effectiveness of such
an approach is dependent on the clear comprehension of
complex interrelationships between variables of different
levels, their cause-effect relations and the development of
adequate intervention methods (Wasserman, Gromov,
Mikhailov, Lynnik, & Flerova, 2002). Such comprehension
implies an in-depth study of psychosomatic and somato-
psychic relationships in DM.
Of prominent importance is the comprehension of the
abovementioned interrelationships in Type 1 DM (DM1).
The influence of DM1 on HRQoL is determined by the
following conditions:
1. DM1 affects principally young people and
accompanies the patient throughout the life period of
expected highest social activity, in particular in
occupation, marital relations, parenting etc. The
manifestation of DM1, in contrast to DM2, is usually
impetuous and is often associated with hospitalization
in critical state. The diagnosis of the disease, bearing
in mind the patients’ age is usually unexpected and
represents a significant psychological trauma for the
youths and their family members. 
2. DM1 implies a real life threat associated with the
development of acute hypo- and hyperglycemic states
and long-term complications (diabetic nephropathy,
retinopathy, polyneuropathy, autonomic neuropathy etc.).
3. Diabetes complications decrease life expectancy (by
10-30%) and its quality, in addition to increasing the
risk of disability (in particular blindness, extremity
amputation etc.). The adverse consequences of the
latter are aggravated by inadequate social protection
of disabled persons.
4. DM1 and its complications in particular frequently
lead to a decrease in the patient’s socioeconomic
status, workplace discrimination, and other social
difficulties. 
5. As a result of the necessity of replacement insulin
therapy, DM1 leads to a reorganization of lifestyle
and habits. The patient is required to observe the
management regimen in order to prevent acute hypo-
and hyperglycemic states and long-term complications.
The diabetes self-care regime includes multiple daily
insulin injections, self-adjustment of insulin dosages,
blood glucose monitoring, dietary restrictions,
additional medication use, and the implementation of
specific procedures for the prevention and treatment
of diabetic complications, etc.
6. As with any chronic disease, although possibly most
pronounced in DM1, the patient has to maintain
sustained contact with health-care establishments.
The inability to adjust to the disease results in an
unfavorable diabetes course and outcome, rapid incapacitation,
and inevitably worsens the patient’s social functioning,
contributes to stigmatization and disruption of significant
relations. Furthermore, it is assumed that the disease has not
only physiological (biological) determinants, but also
psychosocial contributors. This led to the inclusion of DM
in the group of psychosomatic diseases (Alexander, 1950).
At the same time, when the disease is already clinically
manifest, that is, an irrevocable fact, somatopsychic relations
gain in importance, while psychosomatic relations are
characterized by the influence of psychosocial factors on
the disease course and outcome. It is necessary to note that,
in each individual case, there is no unitary direct cause-
effect relation between physical and psychological factors.
The nature of the disease and its effect on the patient’s
HRQoL is determined both by the features of the disease
itself and the state/personality characteristics of the patient.
DM1 may serve as a graphic model of the mutual influence
of psychological and somatic spheres because:
1. It (DM1) gravely influences, although usually not
catastrophically, the lifestyle of the patient.
2. In not many other diseases, the prognosis depends to
such an extent on the adaptive-compensatory potential
of the affected person.
Thus, in DM (and in DM1 in particular), we have to deal
with a complex psychosomatic entirety, the comprehension
of which is necessary for provision of adequate care. 
The conception of DM as a psychosomatic disorder
sprouts from the school of psychoanalysis although, in the
seventeenth century, the British physician and anatomist
Thomas Willis had already noted the link between protracted
negative experiences and the development of diabetes (Rubin
& Peyrot, 2002). 
Later, a description of personality factors predisposing
the person to DM was attempted, that is, the identification
of a specific “diabetic personality” (Dunbar, 1948).
Researchers have failed to reveal specific personality traits
in DM patients (Dunn & Turtle, 1981). However, the fact
that the etiology of the disease is not entirely clear and that
the connection between its prevalence and industrialization
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is observed encourages the continuation of the search for
DM psychosocial preconditions (Korkina & Elfimova, 2004).
In particular, the fact that emotional arousal by activating
sympathetic-adrenergic systems leads to release of
catecholamines resulting in an increase of blood glucose
level, has served as the basis for research into the role of
stress in the development and manifestation of DM.
Empirical findings suggest possible involvement of
psychological stress in the pathogenesis of DM, although
its mechanisms remain unclear (Wales, 1995). 
Data on Type 2 DM (DM2), on the whole, are more
demonstrative (Mooy, de Vries, Grootenhuis, Bouter, &
Heine, 2000): In particular, there is evidence that chronic
stress and stressful life situations lead to impaired glucose
tolerance and an increase in insulin resistance, which are
initial symptoms of DM. Depression is considered to be an
independent risk factor for DM2, although the nature of this
association is not fully explained (Eaton, Armenian, Gallo,
Pratt, & Ford, 1996; Rubin & Peyrot, 2002). Despite the
fact that the significance of stress as an etiological factor
in DM1 has not received empirical support, most researchers
recognize its ability in conjunction with other factors to
precipitate the manifestation of the disease. 
It is important to note that the issue of the influence of
psychosocial factors on the risk of DM represents a specific
aspect of a more general scientific discourse on the so-called
“psychosomatic diseases.” This category has been excluded
from the tenth revision of The International Statistical
Classification of Disease and Related Health Problems (ICD-
10) due to acknowledged role of psychosocial factors in the
etiopathogenesis of practically any disease. This underlines
the need to study subtle mechanisms of mutual influence
of psychological and somatic factors, which form an
indivisible entirety at the stage of manifested disease.
The principal somatic factors specific for DM are
determined by:
1. Glycemic control (degree of success in maintaining
blood glucose levels in the near-normal range).
2. Stability/instability of DM course.
3. Frequency and severity of hypoglycemic states.
4. The degree of hypoglycemia awareness (the ability to
identify the first signs of dangerously low blood glucose). 
5. Presence/absence and severity of long-term
complications (diabetic retinopathy, nephropathy,
neuropathy etc.) 
6. Features of DM and diabetic complication treatment.
7. Presence/absence and severity of comorbid conditions. 
The above-listed factors interact and determine the
peculiarity of the clinical picture in each individual DM
patient. Furthermore, each of the noted factors interacts with
a wide range of other psychosocial factors which in turn
are in a state of mutual inter-influence. The following are
psychosocial variables that are regarded most important by
researchers studying psychosomatic and somatopsychic
interrelationships in DM:
1. Depression, anxiety (de Groot, Anderson, Freedland,
Clouse, & Lustman., 2001; Kohen, Burgess, Catalan,
& Lant, 1998), including fear of hypoglycemia
(Polonsky, Davis, Jacobson, & Anderson, 1992),
blood-injection related anxiety (Mollema, Snoek, Ader,
Heine, & van der Ploeg, 2001).
2. Other emotional and behavioral disturbances (Jacobson
et al., 1997; Wasserman & Trifonova, 2004).
3. Cognitive impairment (Brands, Biessels, de Haan,
Kappelle, & Kessels, 2005).
4. Stress, stressful life events and circumstances (Surwit
& Schneider, 1993).
5. Coping behavior (Rose, Fliege, Hildebrandt, Schirop,
& Klapp, 2002).
6. The personal disease picture, personal model of the
disease (Skinner & Hampson, 2001).
7. Personality traits (Rose et al., 2002).
8. Social support, including that of family, family well-
being (Connell, Davis, Gallant, & Sharpe, 1994;
Glasgow et al., 1997; Skinner, John, & Hampson, 2000).
9. The quality of patient-health care provider
communication. (Glasgow & Anderson, 1999; Heisler,
Bouknight, Hayward, Smith, & Kerr, 2002). 
10. Socio-demographic variables, occupational status,
educational level, level of income, diabetes-related
disability (Glasgow et al., 1997; Lloyd & Orchard,
1999).
Psychosocial issues in diabetes mellitus 
The practical significance of examination of the above-
mentioned factors is determined not only by the possibility
of the improvement of HRQoL and psychosocial functioning
but also (possibly in first place) by the need to promote
behavioral adjustment to the disease, in other words, to
encourage adherence to treatment, as DM, and in particular
DM1 is a disease, the control of which is practically entirely
the onus (95%, according to the data of Anderson, 1985) of
the patient. Fostering of adherence to the diabetes treatment
regimen is one of the principal tasks of the psychologist in
diabetes care (Harris & Lustman, 1998) because the life
expectancy and quality of life of the patient are closely
associated with degree of her/his commitment to self-care. 
As noted by Toljamo and Hentinen (2001), and as
confirmed by practice, adherence to treatment does not
always result in optimal glycemic control. However, failure
to perform self-care procedures usually result in metabolic
decompensation.
Some patients are unable to reach optimal glycemic
control despite their own efforts and the efforts of the
medical team. Sometimes these difficulties in adjustment to
the illness lead to a significant and persistent metabolic
instability with uncontrollable and unpredictable, from the
patient’s point of view, fluctuations in blood glucose level,
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accompanied by frequent episodes of severe hypo- and/or
hyperglycemia (ketoacidosis), resulting in recurrent
hospitalizations. Such a course of the disease is referred to
as “brittle diabetes.” It is most typical of young patients
with DM1, especially young women, but can also be
observed in DM2 (Schade & Burge, 1995).
The etiology and mechanisms of brittle DM are not yet
thoroughly understood. Comorbid medical conditions,
impaired hypoglycemia awareness, insulin resistance,
inappropriate secretion of counterregulatory hormones and
several other physiological conditions are considered to be
of importance. However many researchers emphasize factors
of psychosocial nature (Schade & Burge, 1995; Schade,
Eaton, Drumm, & Duckworth, 1985).
These factors are manifold. Even experienced
practitioners are not always able to detect them. It is probable
that, the absence of obvious physiological grounds for
diabetes “brittleness,” or a disproportion of the observed
metabolic instability to the revealed physiological causes,
should be considered as an evidence of underlying
psychosocial determinants (Schade et al., 1985). These may
include the patient’s inability or reluctance to cooperate with
the health-care team, affective disorders, cognitive and
behavioral disturbances, factitious disease, stress exceeding
the patient’s coping ability, manipulative attitudes, etc. One
should also consider the possibility of insulin omissions (in
particular in women and young patients) in order to attain
weight loss, disturbed eating behavior and eating disorders
(Herpertz et al., 2000).
In order to reveal specific causes of “psychogenic”
brittle DM, it is undoubtedly necessary to carry out a
comprehensive psychological examination. Maximum
benefit can be achieved from an in-depth psychodiagnostic
interview. Such an interview permits an experienced
psychologist, well-informed of the problems typical of DM
patients, not only to identify targets for psychological
interventions, but to clearly formulate aims for additional
experimental- psychological investigation. When choosing
psychodiagnostic tools in “brittle diabetes cases” it is
necessary to take into account the fact that the patient can
consciously or otherwise resist psychological intervention,
adjust her/his responses, use rigid psychological defenses.
Accordingly, the psychologist should consider the
possibility of acquiring additional information about the
patient (from the physician in charge, close relatives, or
friends), and the participation of family members in the
psychodiagnostic and psychotherapeutic process. Sometimes
the use of projective and semi-projective instruments to
reduce the probability of the patient’s “insincerity” is
justified. 
It should be noted that such “difficult” cases in the
psychologist’s practice are relatively rare. More often, the
psychologist is faced with less severe disruptions of
compliance, which are, unfortunately, more often the rule
than the exception in diabetes-care practice.
In fact, it was the problem of nonadherence that made
the health professionals recognize the necessity of
cooperation with psychologists and served as impetus for
large-scale interdisciplinary research into the mechanisms
of the DM patients’ adaptation to their ailment. 
The results of this inquiry have provided valuable
information about the factors affecting the patient’s
willingness to actively participate in treatment process,
cooperate with health-care providers, conform to medical
recommendations and perform self-care procedures in
order to attain a good diabetic control. In particular, it has
been established that the main contributors to
nonadherence are:
1. Psychosocial disturbance (Ciechanowski, Katon, &
Russo, 2000; Lustman et al., 2000);
2. Deficit of coping resources and passive coping
behavior that impede the overcoming of stress, related
or not to the disease (Rose et al., 2002)—“stress-
coping” model;
3. Certain features of the personal picture of the disease,
as opposed to its objective clinical picture (Skinner
& Hampson, 2001)—“health beliefs-health behavior”
model; 
4. Certain features of the patient-physician relationship
(Glasgow & Anderson, 1999).
However, the situation is complicated by the fact that the
above-mentioned factors are evidently intertwined, they interact
with other psychosocial factors, clinical and socio-demographic
features of the individual patient, making the problem of
treatment adherence part and parcel of a more general problem
of psychosocial adjustment. This fact necessitates a
comprehensive investigation, aimed at studying the specifics
of psychosomatic and somatopsychic interrelations in every
individual patient. 
In particular, there are extensive empirical data on the
increased risk of anxiety disorders in patients with DM:
Generalized anxiety disorders are diagnosed in an average
of 14% of DM patients; sub-clinical anxiety symptoms are
manifest in up to 40% of DM patients as compared to 27%
in the general population (Grigsby, Anderson, Freedland,
Clouse, & Lustman, 2002). 
Anxiety of varying severity is typical for practically all
disorders of neurotic nature, and therefore indexes of trait
and state anxiety can be considered criteria for psychological
well-being or otherwise. In DM1 patients, the development
of anxiety is intensified by the frustrating and stressful nature
of life situations caused by the disease. Anxiety is often
associated with the realization of incurable and onerous
nature of the disease, its possible unfavorable social
consequences (at work, in marital relations etc.), the necessity
of change in life-style, and so on. 
Anxiety is a natural reaction to the first signs of long-
term complications because most patients know or see at
times those with severe forms of diabetic complications—
retinopathy, nephropathy, “diabetic foot,” etc. Anxiety may
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also be a component of psycho-organic disorders at late
stages of the disease.
Anxiety symptoms are frequently accompanied by poor
glycemic control and may be erroneously taken for an
indication of metabolic instability (Lustman, 1988). The
shared autonomic component of anxiety and poor glycemic
control significantly complicates differential diagnosis,
especially because emotional instability and unstable blood
glucose mutually exacerbate each other.
It is however necessary to emphasize that DM is a life-
threatening condition in the long-term (due to complications)
and short-term due to acute hypoglycemic states, that is, a
decrease in blood glucose to dangerously low levels. The
risk of life-threatening hypoglycemia is one that the DM
patients have to live with, which may cause a chronic
anticipatory anxiety.
Frequent episodes of hypoglycemia have a negative
impact on the patient’s cognitive functioning, emotional
well-being and HRQoL (Northam, Anderson, Werther,
Warne, & Andrewes, 1999; Wredling, Theorell, Roll, Lins,
& Adamson, 1992). Most affected are patients with impaired
awareness of hypoglycemia. Unexpected and unmanageable
severe hypoglycemia that can occur even at night (the so-
called “nocturnal hypoglycemia”), when the patient is alone
or in the company of unknown people, may cause the feeling
of constant threat and inability to control one’s own life.
Furthermore, hypoglycemia experienced in the presence of
other people may lead to a feeling of embarrassment and
guilt which contribute to limitation of personal contacts and
social isolation. 
As a result, it is of no surprise that in some patients with
DM1, severity of hypoglycemia-related worries allows to
conclude the occurrence of clinically significant anxiety
disorder (F40-F41, F43.2 accordingto ICD-10). Polonsky
and colleagues (1992) regard higher levels of trait anxiety,
difficulty in differentiating symptoms of anxiety and
hypoglycemia, and negative hypoglycemia-related personal
experience as the most significant preconditions for
development of hypoglycemic fear.
The danger of hypoglycemia-related anxiety disorders
lies in that anxiety impedes the recognition of
hypoglycemia as it shows with symptoms similar to those
of hypoglycemia (tremor, tachycardia, perspiration) that
are compensatory responses of the sympathetic nervous
system to decreased blood glucose levels. Furthermore, a
vicious cycle is formed: frequent hypoglycemia episodes
 anxiety  difficulty in differentiating symptoms of
anxiety and hypoglycemia  more frequent episodes of
hypoglycemia + psychosocial dysfunction + increasing
anxiety etc. Fear of hypoglycemia forces the patient to
choose the lesser of two evils and to intentionally maintain
high blood glucose levels. This in turn contributes to the
development and progression of long-term complications,
which are an additional source of distress and psychosocial
disorders.
Among them, the central position is undoubtedly occupied
by depression. It has been documented that, in patients with
DM, depression is on average twice as prevalent as in the
general population (Anderson, Freedland, Clouse, & Lustman,
2001; Talbot & Nouwen, 2000). Furthermore, the risk of
depression is greater in persons with poor glycemic control
(Lustman et al., 2000) and those affected by diabetic
complications (de Groot et al., 2001). Researchers indicate
the role of biological, genetic, social, and psychological
factors in the development of depressive disorders in DM
(Talbot & Nouwen, 2000). Underscored is the need to regard
the comorbid depression an important treatment target. Apart
from the increased risk, some researchers (Lustman, Griffith,
& Clouse, 1988) have noted that, on the whole, the course
of depression in DM is less favorable than in the absence of
chronic somatic comorbidity, with somewhat more protracted
depressive episodes and a greater risk of relapses. The cause
of this, as with the higher risk of depression in DM, remains
unclear and may be related to genetic predisposition,
biochemical shifts, and chronic disease-related stress.
Depression being a disorder difficult to treat in itself,
when present with somatic comorbidity (and in particular
with DM), takes on special significance, as it:
1. Impairs regimen adherence, causing deterioration of
metabolic control (Ciechanowski et al., 2000; Lustman
et al., 2000);
2. Decreases effectiveness of patient-provider communication
(Jackson & Kroenke, 1999; Katon, 2003);
3. Is directly (independent of regimen adherence)
associated with hyperglycemia (Lustman, Clouse,
Ciechanowski, Hirsch, & Freedland, 2005);
4. Increases diabetes-related mortality (Zhang et al.,
2005), and the likelihood of microvascular and
macrovascular complications and disability (Black,
Markides, & Ray, 2003; Clouse et al., 2003);
5. Decreases the patient’s HRQoL (Jacobson et al., 1997;
Lustman et al., 2000).
All of the above-mentioned circumstances are links in
pathological interrelations causing the exacerbation of
psychiatric and somatic disorders. For example, poor
treatment adherence in a patient with depressive disorder
by increasing specific DM metabolic imbalance worsens the
general somatic state of the patient, precipitates the
development of long-term complications and may provoke
acute hyper- or hypoglycemia and hospitalization, thus
increasing stress and inevitably exacerbating affective
disorders. Ineffective communication between a depressed
patient and health-care providers may contribute to the
formation of distorted (mostly negative) subjective
conceptions of the disease and treatment, leading to a
worsening of the somatic status, feelings of helplessness,
hopelessness, and loss of trust in the doctor, etc.
Psychotherapy and psychopharmacological treatment of
depression not only relieves the patients of distressing
worries, but significantly enhances their general well-being,
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restores normal sleep and eating habits, which are of great
importance in DM, improves physical activity, compliance
and metabolic control (Lustman & Clouse, 2002). However,
these potential benefits often remain a promise, due to noted
underrecognition of depression in persons with DM. In
particular, according to Rubin, Ciechanowski, Egede, Lin,
and Lustman (2004), early diagnosis and treatment of
depression occurs in less that 25% of cases.
Such circumstances are largely explained by the rising
prevalence of masked depressions and somatoform disorders.
It is no surprise that the endocrinologist prefers to see in evident
autonomic symptoms signs of metabolic decompensation, and
in complaints of persistent pain signs of diabetic polyneuropathy,
and not of the patient’s psychological suffering, especially in
view of the fact that one state usually accompanies the other. 
As is clear from the above, psychosocial disturbances
in DM, and in particular DM1, play a vital role as elements
of circular psychosomatic and somatopsychic interrelations.
Thus, assessment of severity and clarification of pathogenesis
mechanisms of these disorders are obligatory conditions for
the prevention of diabetic complications, the optimization
of psychosocial functioning and improvement of HRQoL. 
Evaluation and treatment of affective disorders acquire
particular significance due to the fact that research have
presented convincing confirmation of their psychological
underlying mechanisms in DM, that is, the possibility to
consider their increased prevalence as a result of chronic
diabetes-related emotional stress (Talbot, Nouwen, Gingras,
Belanger, & Audet, 1999). In other words, emotional
disturbances often represent the affective level of the personal
(subjective) disease picture. This level, on its own and in
interaction with cognitive and behavioral levels, determines
the quality of the disease-related experience and the personal
meaning of illness. 
It may be concluded that, in many patients, revealed
affective (depressive and anxiety) symptoms are the result
of poor adjustment to the disease, contributed to by general
social frustration (including a low level of social support)
and increased stress in combination with insufficient coping
ability or the preference of unconstructive coping strategies
(Wasserman, et al., 2002).
Successful overcoming of stressful situations, including
DM itself and its consequences, is dependent on the patient’s
effective coping strategies. The importance of a rational,
problem-focused coping style has been supported in a
number of studies, and some researchers have indicated
coping style as the main factor facilitating the patient’s
adjustment (Rose et al., 2002).
The importance of the “stress-coping” complex in
relation to diabetic control is confirmed on one hand by the
ability of stressful situations to lead to an increase of average
blood glucose concentrations (Goldston, Kovacs, Obrosky,
& Iyengar, 1995; Wrigley & Mayou, 1991), and on the other
hand, by the ability of active problem-focused behavior to
lead to better psychosocial and diabetes outcomes (Griffith,
Field, & Lustman, 1990; Rose et al., 2002; Seiffge-Krenke
& Stemmler, 2003).
The patient’s ability to cope with stressful situations
gains importance in the light of the results of a study by
Peyrot and McMurry (1992), who noted that stress was
associated with poor glycemic control only in patients using
ineffective coping strategies. In other words, effective coping
can protect an individual from the adverse effects of stress.
Thus, the effectiveness of coping behavior is connected to
general psychosocial adjustment of DM patients and to their
mental and physical health outcomes, making the assessment
of coping styles necessary for adequate prevention of
psychosocial disturbances, nonadherence, and metabolic
decompensation in DM.
Of no lesser importance than the patients’ way of coping
with diabetes-related stress is their social environment. An
increased risk of social frustration as a result of failure to
satisfy one’s social needs (Wasserman, 1995) and often
stigmatization in DM persons is caused not only by
“physical” aspects of the disease, but also by insufficient
attention of society to the needs of DM patients, attempts
to create in them a sense of inferiority, ignorance, etc.
Perceived inadequacy of social support as one of the most
important coping resources significantly reduces adjustment
possibilities of the personality. Positive social support can
act as a buffer, reducing the link between severe somatic
pathology and depression (Connell et al., 1994), and also
between stress and glycemic control (Griffith, et al., 1990).
The significance of social milieu is particularly prominent
for children and adolescents (Hauser et al., 1990). Family
conflicts, disregard for the child’s needs and interests, insufficient
attention to the disease management inevitably lead to metabolic
decompensation and, when becoming a chronic condition,
contributes to rapid development of long-term complications.
Not only medical outcome, but also the consequent psychosocial
adjustment is dependent on the family’s health-promoting
attitude towards the child’s ailment. It is also important to take
into account the fact that the disease in a child (adolescent) is
a major stressor for the entire family, which, as a self-organizing
system, should choose its own coping strategy.
Indirect evidence for the significance of constructive
coping behavior comes from the research on the efficacy of
coping skills trainings (Hampson et al., 2001), which are
often included in standard diabetes educational programs.
The positive effect of the latter as shown by research
(Brown, 1992) is significant, although temporary. Knowledge
of the diabetes self-care rules is a necessary though
insufficient condition for a strict treatment adherence. This
fact emphasizes the importance of personality-mediated
disease perception and the attitude towards, which determine
the patient’s health behavior. 
Actually, the subjective disease picture, as a disease-
related cognitive-affective-behavioral complex that reflects
its personal meaning for the patient, should be of first
importance for the clinical psychologist (Lipowski, 1983;
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Luria, 1977; Nikolaeva, 1987; Wasserman & Zaitsev, 1990).
This is determined primarily by its integrated nature,
including the following levels.
1. Cognitive level: The patient’s conception of the disease
(evaluation of its danger, conception of its nature, its
causes and consequences, subjective prognosis and
the possibility to influence its course, beliefs about
efficacy of available treatment and personal ability
to perform self-care procedures, etc.) .
2. Affective level: The patient’s emotional reaction to the
disease and its consequences. Fear, anxiety, depression,
sorrow, guilt, resentment, and anger are all emotions
the combination of which may occur at various stages
of the realization of the disease and may be an entirely
natural reaction to such a psycho-traumatic event. The
intensity and persistence of negative emotions due to
the ailment may reach clinically significant levels
(depression, anxiety), the deleterious consequences of
which are described above. 
3. Behavioral level: This level includes diabetes self-
care, ways of coping with disease-related stressors,
the manner of communication with medical personnel,
extent of physical activity, changes in habits, etc. 
The nature of personal disease picture depends both on its
objective characteristics (its course, complication severity and
vital risk, objective functional limitations caused by the disease,
etc.) and the personality of the patient (the extent of her/his
emotional stability, coping-style, personal value systems, social
environment, socio-demographic characteristics, etc.).
On the other hand, the patient’s attitude towards the
disease has an effect on his/her somatic state. In particular,
the intensity of depressive component within a personal
disease picture significantly worsens prognosis as it manifests
itself in the following phenomena: 
1. On the cognitive level: perception of the hopelessness
of one’s state, personal helplessness, belief in one’s
“inadequacy,” etc.;
2. On the emotional level: sadness, apathy, guilt, etc.;
3. On the behavioral level: gross disruptions of
compliance, limitation of social contacts, and decrease
in physical activity.
Thus, the result of the assessment of the degree and nature
of social frustration, the patients’ coping behavior and their
attitude towards the disease can be fruitfully implemented
in psycho-preventive work aimed at improving HRQoL.
Methodological principles of health-related quality
of life assessment in diabetes mellitus
All the above-mentioned allows the conclusion that the
HRQoL of DM1 patients is formed by interplay between
variables of psychosocial and physical levels. Investigation
and, if required, correction of the psychological component
should be the principal concern of mental health specialists—
clinical psychologists, psychiatrists and psychotherapists—
acting in close cooperation with endocrinologists and other
medical specialists. 
Psychodiagnostic (both experimental and clinical)
investigation in this case should be carried out with the tools
(Wasserman & Shchelkova, 2004) covering the following
information:
1. The patient’s current emotional state, dominant
tendencies within emotional (neurosis-like) disturbance
(e.g., anxiety-phobic, depressive-hypochondriac
tendencies, etc.), symptoms of somatization, initial
signs of psychological maladjustment. The ratio of
somatogenic and psychogenic components in
psychological dysfunction (when revealed).
2. Association between emotional disturbance, the
patient’s subjective model of the disease and health-
related behavior—the personal disease picture.
3. The patient’s way of coping with individually
significant stressors including the disease itself, its
physical and social consequences. Of importance is
also information on mechanisms of psychological
defense as a way to overcome anxiety.
4. The level of social frustration and in particular, degree
and quality of social support.
In accordance to the required information, the
psychologist working with diabetic patients should carry
out comprehensive experimental-psychological investigations,
including the following set of methods:
1. Several instruments or multi-scale questionnaires
designed to measure the presence and severity of
psychiatric symptoms, such as the Minnesota
Multiphasic Personality Inventory (MMPI; Hathaway
& McKinley, 1951, 1967), the Symptom Check List-
90-Revised (SCL-90-R; Derogatis, 1983), The Hospital
Anxiety and Depression Scale (HADS; Zigmond &
Snaith, 1983), State-Trait Anxiety Inventory (STAI;
Spielberger, Gorsuch, Lushene, Vagg, & Jacobs ,
1983), the Beck Depression Inventory (BDI; Beck,
Ward, Mendelson, Mock, & Erbaugh, 1961), Self-
Rating Depression (SDS; Zung, 1965), etc. 
2. Comprehensive instruments for the examination of
cognitive, affective and behavioral components of
disease perception. For example the Questionnaire
for Psychological Diagnosis of Attitudes towards
Disease (TATD; Wasserman, Iovlev, Karpova, & Vuks,
2005), developed in the laboratory of clinical
psychology of the V.M. Bekhterev Institute. 
3. Measures of coping behavior (including the way of
coping with disease-related stressors), for example,
the Ways of Coping Questionnaire (WCQ; Folkman
& Lazarus, 1988), the COPE scale, (COPE; Carver,
Scheier, & Weintrub, 1989), the Coping Inventory for
Stress Situations (CISS; Endler, & Parker, 1990), the
Zurich Questionnaire of Coping with Illness (ZKV;
Sieber, Buddeberg, & Wolf, 1991), etc.
4. Measures of social frustration and social support, for
example, the Social Support Questionnaire (SSQ;
Sarason, Levine, Bashman, & Sarason, 1983), the
Interpersonal Support Evaluation List (ISEL; Cohen
& Hoberman, 1983), etc. 
Information acquired using such an approach allow a
holistic conception of the patient’s psychological adjustment
to DM, understanding of the possible causes of poor
emotional adaptation, and identification of intervention targets.
Where necessary, the battery can be expanded in accordance
with the purposes of psycho-preventive intervention, in
particular by personality questionnaires, neurocognitive
assessment tools, “family diagnosis” techniques (examination
of family relationships), projective measures for identification
of unconscious conflicts and defense mechanisms, etc.
Undoubtedly, psychological assessment, especially in
outpatient conditions should be carefully balanced between
thoroughness of examination and limited time resources. A
multidimensional psychological assessment of each DM1
patient irrespective of its potential benefit may be justified
only in presence of evident adjustment impairment requiring
psychological correction. In all other cases, necessary and
sufficient would apparently be the use of time-saving screening
instruments. Such are a multitude of HRQoL measures.
Application of HRQoL questionnaires provides preliminary
information on the influence of the disease on the patient’s
satisfaction within various life-domains, and the illness impact
on the patient’s life. In the case of diabetes-specific quality
of life (QoL), one can assess the impact of DM. 
Currently there are many tools designed to measure
diabetes-related QoL. For instance:
1. Audit of Diabetes-Dependent Quality of Life
(ADDQoL; Bradley et al., 1999). This consists of 13
items and is designed to assess the influence of the
disease on the patient’s daily activity.
2. Diabetes-39 (D-39; Boyer & Earp, 1997). This
instrument consists of 39 items, permits the assessment
of HRQoL in DM, it covers five dimensions of
functioning: Energy and mobility, Diabetes control,
Anxiety and worry, Social burden, and Sexual
functioning. 
3. Diabetes Health Profile (DHP-1, DHP-18; Meadows
et al., 1996). It consists of 32 items, aimed at the
assessment of HRQoL in DM patients requiring
insulin replacement therapy, includes three scales:
Psychological distress, Barriers to activity, and
Disinhibited eating.
4. Problem Areas in Diabetes (PAID; Polonsky et al.,
1995). This instrument consists of 20 items and is
intended for the assessment of diabetes-related
emotional distress.
5. Diabetes Quality of Life Measure (DQOL; Jacobson,
Barofsky, Cleary, & Rand, 1988). It consists of 46
items and is designed to assess HRQoL in DM1,
primarily in youths. The questionnaire includes four
scales: Life satisfaction, Diabetes impact, Worries
about diabetes, and Social/vocational concerns.
6. Diabetes-Specific Quality-of-Life Scale (DSQOL;
Bott, Mühlhauser, Overmann, & Berger, 1998). This
instrument consists of 64 items intended for the
assessment HRQoL in DM1. The questionnaire
includes a section covering individual treatment aims,
a section covering satisfaction with treatment
effectiveness, and six scales assessing the influence
of DM1 on daily functioning: Social relations, Somatic
complaints, Worries about the future, Leisure, Dietary
limitations, and Treatment satisfaction.
There are several other instruments for diabetes-specific
QoL assessment and the number is constantly growing. The
advantage of applying diabetes-related QoL questionnaires
is determined by the fact that these instruments:
1. Are specifically designed for this group of patients
and with specifics of the disease and its potential
impact on daily life taken into consideration;
2. Most of them are not time-consuming;
3. Allow preliminary assessment of the patient’s
functional limitations, psychological status and social
functioning;
4. Allow identification of patients at risk for poor
adjustment to the disease;
5. Generally have good face validity: their content is
well understood by patients and does not cause them
to consider themselves to be “mentally ill”;
6. May be administered by medical personnel without
the risk of being misinterpreted by patients and
opposition to investigation;
7. When used by the physician in charge, these
questionnaires permit some objectiveness in assessment
of treatment effectiveness and enhance patient-provider
communication;
8. In combination with clinical data, they can be used
to assess efficacy of therapeutic measures.
The practical significance of HRQoL assessment is
furthermore determined by the fact that the concept HRQoL
can be fruitfully implemented in order to improve the
cooperation between specialists of varying fields (physicians,
psychologists, social workers). 
It is also necessary to note that HRQoL assessment and
even in-depth analysis of the patient’s diabetes-specific
problems (diet maintenance difficulty, fear of hypoglycemia,
concerns about the influence of the disease on occupational
functioning, mobility etc.) do not allow understanding of
mechanisms underlying the empirically ascertained HRQoL.
Validation of the majority of HRQoL assessment instruments
in DM involves the attainment of significant correlations
between objective measures of disease severity (the number
of long-term complications, glycosylated hemoglobin
concentration etc.) and indices of the patient’s emotional
state, the adequacy of perceived social support, and so on.
Therefore, to determine the targets for further treatment and
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psychological interventions, it is necessary to clarify specific
mechanisms involved in the formation of quantitative and
qualitative characteristics identified with the use of a HRQoL
questionnaire.
Assessment of HRQoL is but the first step in research
into adaptation mechanisms of each individual patient in
each specific circumstance; however, this step is of great
significance, as it leads to the enhancement of patient-
physician cooperation which is necessary for implementation
of comprehensive treatment of DM patients.
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